Følg
Ian Watson
Ian Watson
Associate Professor, McGill University
Verifisert e-postadresse på mcgill.ca
Tittel
Sitert av
Sitert av
År
A landscape of driver mutations in melanoma
E Hodis, IR Watson, GV Kryukov, ST Arold, M Imielinski, JP Theurillat, ...
Cell 150 (2), 251-263, 2012
29212012
Genomic Classification of Cutaneous Melanoma
TCGA Network
Cell 161 (7), 1681-96, 2015
2656*2015
Melanoma genome sequencing reveals frequent PREX2 mutations
MF Berger, E Hodis, TP Heffernan, YL Deribe, MS Lawrence, ...
Nature 485 (7399), 502-506, 2012
8772012
Emerging patterns of somatic mutations in cancer
IR Watson, K Takahashi, PA Futreal, L Chin
Nature Reviews Genetics 14 (10), 703-718, 2013
5682013
Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations
M Dankner, AAN Rose, S Rajkumar, PM Siegel, IR Watson
Oncogene 37 (24), 3183-3199, 2018
4022018
NEDD8 pathways in cancer, Sine Quibus Non
IR Watson, MS Irwin, M Ohh
Cancer cell 19 (2), 168-176, 2011
2032011
The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF
IR Watson, L Li, PK Cabeceiras, M Mahdavi, T Gutschner, G Genovese, ...
Cancer research 74 (17), 4845-4852, 2014
1802014
Immature low-density neutrophils exhibit metabolic flexibility that facilitates breast cancer liver metastasis
BE Hsu, S Tabariès, RM Johnson, S Andrzejewski, J Senecal, C Lehuédé, ...
Cell reports 27 (13), 3902-3915. e6, 2019
1672019
Why is melanoma so metastatic?
RR Braeuer, IR Watson, CJ Wu, AK Mobley, T Kamiya, E Shoshan, ...
Pigment cell & melanoma research 27 (1), 19-36, 2014
1472014
Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function
IR Watson, A Blanch, DCC Lin, M Ohh, MS Irwin
Journal of biological chemistry 281 (45), 34096-34103, 2006
1402006
Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity
A Blanch, F Robinson, IR Watson, LS Cheng, MS Irwin
PLoS One 8 (6), e66436, 2013
1292013
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
R Somasundaram, G Zhang, M Fukunaga-Kalabis, M Perego, C Krepler, ...
Nature communications 8 (1), 607, 2017
1282017
Ablation of adipocyte creatine transport impairs thermogenesis and causes diet-induced obesity
L Kazak, JF Rahbani, B Samborska, GZ Lu, MP Jedrychowski, M Lajoie, ...
Nature metabolism 1 (3), 360-370, 2019
1252019
Suppression of hypoxia-inducible factor 2α restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells
AM Roberts, IR Watson, AJ Evans, DA Foster, MS Irwin, M Ohh
Cancer research 69 (23), 9056-9064, 2009
1152009
Ubiquitin and ubiquitin-like modifications of the p53 family
IR Watson, MS Irwin
Neoplasia 8 (8), 655-666, 2006
1122006
Single-cell spatial immune landscapes of primary and metastatic brain tumours
E Karimi, MW Yu, SM Maritan, LJM Perus, M Rezanejad, M Sorin, ...
Nature 614 (7948), 555-563, 2023
1022023
Chemotherapy induces NEDP1-mediated destabilization of MDM2
IR Watson, BK Li, O Roche, A Blanch, M Ohh, MS Irwin
Oncogene 29 (2), 297-304, 2010
792010
Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigration
SAC McDowell, RBE Luo, A Arabzadeh, S Doré, NC Bennett, V Breton, ...
Nature Cancer 2 (5), 545-562, 2021
742021
Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies
S Rajkumar, IR Watson
British journal of cancer 115 (2), 145-155, 2016
742016
Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response
IIL Hwang, IR Watson, SD Der, M Ohh
Journal of virology 80 (21), 10712-10723, 2006
742006
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20